Intrinsic Value of S&P & Nasdaq Contact Us

Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
$25.54
+45.2%
Analyst Price Target
$19.75
+12.3%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Baxter International Inc. (BAX) has shown moderate revenue growth over the past 3 years, expanding from $10.1B to $11.2B (average +3.8%/yr). The company reported a net loss of $957M in its most recent fiscal year, with earnings trending at 12.4%/yr. The net profit margin is -8.5%, which is negative. the company was profitable in 1 out of the last 4 years tracked. The gross margin is 30.1% (moderate), with a -5.2pp trend over the period. With a $9B market cap and MOAT composite score of 49/100, the company has a moderate competitive position.

Criteria proven by this page:

  • GROWTH (63/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (25/100, Fail) — the company has frequently reported losses. Looking at the full 41-year history, the company was profitable in 37 of 41 years — an excellent long-term track record
  • INCOME (10/100, Fail) — the company is currently operating at a loss
  • MOAT (49/100, Partial) — some competitive advantages are present but not dominant

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.

43/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
25/100
1/4 yrs profit
EPS –$1.75
Proven by this page
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
49/100
Score: 49/100
GM 30.1% (-5.2pp)
Proven by this page
GROWTH
63/100
Rev +3.8%/yr
NI +12.4%/yr
Proven by this page
INCOME
10/100
Margin -8.5%
$11.2B
Proven by this page
Baxter International Inc. Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $11.24B$11.24B$10.64B$10.36B$10.06B
Gross Profit $3.38B$3.38B$3.98B$4.15B$3.55B
Gross Margin 30.1%30.1%37.5%40.1%35.3%
Operating Income $-308M$-308M$14M$707M$-2.85B
Net Income $-957M$-957M$-649M$2.66B$-2.43B
Net Margin -8.5%-8.5%-6.1%25.6%-24.2%
EPS (Diluted) $-1.82$-1.75$-1.27$5.23$-4.83
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message